Schaffer P, Renaud R, Gairard B, Guldenfels C
Faculté de Médecine, Laboratoire d'Epidémiologie et de Santé Publique, Strasbourg.
Rev Epidemiol Sante Publique. 1996;44 Suppl 1:S15-21.
Cancer registries are necessary to evaluate the efficacy of cancer screening programmes. They provide early indicators of screening efficacy, needed to correct certain campaign failings without waiting for the mortality data, available only 7 to 10 years after the beginning of the screening. They allow to mesure the screening effect not only on the screened women, but also on the entire target population. They also allow to mesure the negative and deleterious effects of the screening. Finally, they are essential to all cost/efficacy study. The evaluation of the breast cancer screening programme in the French department of Bas-Rhin by the cancer Registry showed very quickly the interest of the mesures concerning the quality assurance programme and to estimate on the first screen results basis, that it will be difficult to reduce the mortality by breast cancer to 25%.
癌症登记对于评估癌症筛查项目的效果至关重要。它们提供筛查效果的早期指标，这对于纠正某些活动中的不足是必要的，而无需等待仅在筛查开始7至10年后才可得的死亡率数据。它们不仅能衡量筛查对接受筛查女性的效果，还能衡量对整个目标人群的效果。它们还能衡量筛查的负面和有害影响。最后，它们对于所有成本/效果研究都至关重要。癌症登记处对法国下莱茵省乳腺癌筛查项目的评估很快显示出有关质量保证项目措施的重要性，并基于首次筛查结果估计，将乳腺癌死亡率降低到25%会很困难。
